SCHEMBL760000

SCHEMBL760000

CC(C)(C)OC(=O)n1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)cn1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 13/20 0.52
ROCK2 O75116 4/20 0.51
PLK4 O00444 3/20 0.51
MAPK13 O15264 3/20 0.51
PDPK1 O15530 3/20 0.51
DAPK3 O43293 3/20 0.51
CHEK2 O96017 3/20 0.51
PRKCG P05129 3/20 0.51
CDK1 P06493 3/20 0.51
PRKACA P17612 3/20 0.51
CDK2 P24941 3/20 0.51
MARK3 P27448 3/20 0.51
AKT2 P31751 3/20 0.51
FLT4 P35916 3/20 0.51
CSNK1D P48730 3/20 0.51
GSK3A P49840 3/20 0.51
GSK3B P49841 3/20 0.51
RPS6KA3 P51812 3/20 0.51
LIMK1 P53667 3/20 0.51
MAPK12 P53778 3/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10269404 0.74 MAPKAPK2 (0.60) MAPKAPK2ROCK2PLK4MAPK13PDPK1
SCHEMBL10269106 0.73 MAPKAPK2 (0.51) MAPKAPK2ROCK2PLK4MAPK13PDPK1
SCHEMBL10213401 0.73 MAPKAPK2 (0.53) MAPKAPK2ROCK2PLK4MAPK13PDPK1
SCHEMBL10213397 0.73 MAPKAPK2 (0.59) MAPKAPK2ROCK2PLK4MAPK13PDPK1
SCHEMBL12393059 0.73 MAPKAPK2 (0.55) MAPKAPK2ROCK2PLK4MAPK13PDPK1
SCHEMBL10213410 0.72 MAPKAPK2 (0.55) MAPKAPK2ROCK2PLK4MAPK13PDPK1
SCHEMBL10213533 0.71 MAPKAPK2 (0.60) MAPKAPK2ROCK2PLK4MAPK13PDPK1
SCHEMBL10213448 0.71 MAPKAPK2 (0.49) MAPKAPK2ROCK2PLK4MAPK13PDPK1
SCHEMBL758237 0.71 MAPKAPK2 (0.52) MAPKAPK2ROCK2PLK4MAPK13PDPK1
SCHEMBL10213524 0.71 MAPKAPK2 (0.52) MAPKAPK2ROCK2PLK4MAPK13PDPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120053345-A1 Indazole Compounds ABBOTT LABORATORIES (US) 2012-03-01 US disclosed
US-8008481-B2 Indazole compounds ABBVIE INC. 2011-08-30 US disclosed
US-20070282101-A1 Indazole compounds ABBVIE INC. 2007-12-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070282101-A1 Indazole compounds CYP3A43, CYP3A7, UGT1A1 MAPKAPK2 1905/4885ROCK2 3219/4885PLK4 1716/4885
US-20120053345-A1 Indazole Compounds CYP3A43, CYP3A7, UGT1A1 MAPKAPK2 1905/4885ROCK2 3219/4885PLK4 1716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.